Terry Dagnon

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terry Dagnon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. Chief Operations Officer Common Stock 653,058 $741,221 $1.14 20 Apr 2023 Direct
Outlook Therapeutics, Inc. Chief Operations Officer Stock Option (Right to Buy) 192,143 17 Apr 2023 Direct

Insider Reports Filed by Terry Dagnon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 20 Apr 2023 1 -$590,200 4 Chief Operations Officer 21 Apr 2023, 21:05
OTLK Outlook Therapeutics, Inc. 17 Apr 2023 1 $0 4 Chief Operations Officer 19 Apr 2023, 17:41
OTLK Outlook Therapeutics, Inc. 21 Jun 2022 1 +$10,500 4 Chief Operating Officer 23 Jun 2022, 17:08
OTLK Outlook Therapeutics, Inc. 31 Mar 2022 1 $0 4 Chief Operating Officer 04 Apr 2022, 18:46
OTLK Outlook Therapeutics, Inc. 21 Dec 2021 1 $0 4 Chief Operating Officer 23 Dec 2021, 16:31
OTLK Outlook Therapeutics, Inc. 06 Dec 2021 1 +$34,777 4 Chief Operating Officer 06 Dec 2021, 16:26
OTLK Outlook Therapeutics, Inc. 03 Dec 2021 1 +$14,200 4 Chief Operating Officer 03 Dec 2021, 15:32